A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
Clinical trial NCT04611152 · TERMINATED
Trial details
- NCT number
- NCT04611152
- Sponsor
- Kodiak Sciences Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-05-11
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.